Ground News

News from Suzhou, China

Stay current with all the latest and breaking news about Suzhou, China, compare headlines and perspectives between news sources on stories happening today. In total, 52stories have been published about Suzhou, China which Ground News has aggregated in the past 3 months.

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Suzhou, China News

FDA · Suzhou

SRIHER Spine Surgery Team Wins Research Award in Seoul

61% Center coverage: 41 sources

SRIHER spine surgery team wins Best International Research Award for groundbreaking research on Wnt signaling pathway in spinal cord injuries.See the Story

Suzhou, China · Suzhou

Innovent's Dual-Action Obesity Drug Takes On Semaglutide: Phase 3 Trial Reveals 73% Liver Fat Reduction

86% Center coverage: 15 sources

New head-to-head trial compares mazdutide vs semaglutide in 470 patients. Previous data showed 73% liver fat reduction. See full Phase 3 details.See the Story

Suzhou, China · Suzhou

Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies

75% Center coverage: 8 sources

SAN FRANCISCO and SUZHOU, China, May 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major…See the Story

News from Suzhou, China

News from Suzhou, China

Local News Publishers

Top Suzhou, China News

SRIHER Spine Surgery Team Wins Research Award in Seoul

Innovent's Dual-Action Obesity Drug Takes On Semaglutide: Phase 3 Trial Reveals 73% Liver Fat Reduction

Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies

Local News Publishers

Local News Publishers

Local News Publishers

Top Suzhou, China News

SRIHER Spine Surgery Team Wins Research Award in Seoul

Innovent's Dual-Action Obesity Drug Takes On Semaglutide: Phase 3 Trial Reveals 73% Liver Fat Reduction

Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies

Exclusive Global 20 Seats, China's Sole One! KT-939 Was Successfully Selected for 2025 NYSCC Inspiration Hive Zone

AccurEdit Therapeutics’ ART001 Becomes China’s First Gene Editing Therapy to Receive FDA Regenerative Medicine Advanced Therapy (RMAT) Designation

Harmontronics Automation files lawsuit against CATL, subsidiaries over delayed payments

Porton Advanced Announces Collaboration with TongEYE to Accelerate Development of iPSC-RPEC transplantation therapy

Porton Advanced Announces Collaboration with Hualong Biological to Accelerate MATC Cell Therapy Development for Solid Tumor Treatment Breakthroughs

Xilu Garden Observation Tower / atelier mearc

Hypebeast Community Center: Office H

Hands-on: Bear Sunny transition lenses for AR glasses